BMC Cancer
- CHU Z, Yang S, Li Q, Shang J, et al
The V protein in oncolytic Newcastle disease virus promotes HepG2 hepatoma cell
proliferation at the single-cell level.
BMC Cancer. 2023;23:346.
- GAO X, Jiang P, Wei X, Zhang W, et al
Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma
via anti-angiogenesis and cytotoxicity.
BMC Cancer. 2023;23:359.
BMC Gastroenterol
- SUMIYOSHI S, Kiuchi J, Kuriu Y, Arita T, et al
Postoperative liver dysfunction is associated with poor long-term outcomes in
patients with colorectal cancer: a retrospective cohort study.
BMC Gastroenterol. 2023;23:128.
- YANG L, Wang YR, Mou ZQ, Xiong PF, et al
A new prediction model of hepatocellular carcinoma based on N7-methylguanosine
modification.
BMC Gastroenterol. 2023;23:131.
Cancer Res
- WOOD CS, Pennel KAF, Leslie H, Legrini A, et al
Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups
in Patients with Colorectal Cancer and Synchronous Liver Metastases.
Cancer Res. 2023;83:1329-1344.
- FANG JH, Chen JY, Zheng JL, Zeng HX, et al
Fructose Metabolism in Tumor Endothelial Cells Promotes Angiogenesis by
Activating AMPK Signaling and Mitochondrial Respiration.
Cancer Res. 2023;83:1249-1263.
Dig Dis Sci
- MAHMUD N, Reddy KR, Taddei TH, Kaplan DE, et al
Type of Infection Is Associated with Prognosis in Acute-on-Chronic Liver Failure:
A National Veterans Health Administration Study.
Dig Dis Sci. 2023;68:1632-1640.
- UNALP-ARIDA A, Ruhl CE
Prepandemic Prevalence Estimates of Fatty Liver Disease and Fibrosis Defined by
Liver Elastography in the United States.
Dig Dis Sci. 2023;68:1237-1252.
- KHAKOO NS, Sultan S, Reynolds JM, Levy C, et al
Efficacy and Safety of Bezafibrate Alone or in Combination with Ursodeoxycholic
Acid in Primary Biliary Cholangitis: Systematic Review and Meta-Analysis.
Dig Dis Sci. 2022 Sep 30. pii: 10.1007/s10620-022-07704.
- JAMMA T
SALL4 Expression in Epithelial Gastric Cancer: Epigenetic or Epiphenomenon?
Dig Dis Sci. 2023 Mar 6. doi: 10.1007/s10620-022-07791.
- PATERNOSTRO R
Muscle Mass Effect: The Importance of Diagnosing and Treating Sarcopenia in
Patients with Advanced Chronic Liver Disease.
Dig Dis Sci. 2023;68:1089-1090.
Eur Radiol
- SAID D, Carbonell G, Stocker D, Hectors S, et al
Semiautomated segmentation of hepatocellular carcinoma tumors with MRI using
convolutional neural networks.
Eur Radiol. 2023 Apr 18. doi: 10.1007/s00330-023-09613.
Gastrointest Endosc
- NAGA M, Naga YM
Duodenal varices injection therapy.
Gastrointest Endosc. 2023;97:997-998.
- HASHIMOTO Y, Miyagaki A
Peroral cholangioscopic findings of acute ischemic cholangiopathy caused by
transarterial chemoembolization.
Gastrointest Endosc. 2023 Jan 13:S0016-5107(23)00021.
Hepatology
- TAPPER EB, Ospina E, Salim N, Chen X, et al
Lactulose therapy for patients with cirrhosis, portal hypertension, and poor
patient reported outcomes - the Mi-Kristal RCT.
Hepatology. 2023 Apr 18. doi: 10.1097/HEP.0000000000000408.
- MALHI H, Shah V, Gores GJ
Thematic reviews: the future of hepatology.
Hepatology. 2023 Apr 19. doi: 10.1097/HEP.0000000000000409.
- UFERE NN
Home is where the liver is?: moving beyond readmissions to time at home as a
patient-centered and pragmatic quality measure in cirrhosis care.
Hepatology. 2023 Apr 21. doi: 10.1097/HEP.0000000000000415.
- MATHUR M, Yeh YT, Arya RK, Jiang L, et al
Adipose lipolysis is important for ethanol to induce fatty liver in the National
Institute on Alcohol Abuse and Alcoholism murine model of chronic and binge
ethanol feeding.
Hepatology. 2023;77:1688-1701.
- JUAREZ-FERNANDEZ M, Goikoetxea-Usandizaga N, Porras D, Garcia-Mediavilla MV, et al
Enhanced mitochondrial activity reshapes a gut microbiota profile that delays
NASH progression.
Hepatology. 2023;77:1654-1669.
- ZABRANSKY DJ, Danilova L, Leatherman JM, Lopez-Vidal TY, et al
Profiling of syngeneic mouse HCC tumor models as a framework to understand
anti-PD-1 sensitive tumor microenvironments.
Hepatology. 2023;77:1566-1579.
- LUO W, Wang Y, Li Y, Zhang T, et al
Letter to the editor: Adipose lipolysis is important for ethanol to induce fatty
liver in the NIAAA murine model of chronic and binge ethanol feeding.
Hepatology. 2023;77:E88-E89.
- ZHANG S, Wan D, Zhu M, Wang G, et al
CD11b + CD43 hi Ly6C lo splenocyte-derived macrophages exacerbate liver fibrosis
via spleen-liver axis.
Hepatology. 2023;77:1612-1629.
- WEN Y, Emontzpohl C, Xu L, Atkins CL, et al
Interleukin-33 facilitates liver regeneration through serotonin-involved
gut-liver axis.
Hepatology. 2023;77:1580-1592.
- CUCCHETTI A, Casadei-Gardini A
Liver resection for HCC in patients with metabolic syndrome: questions answered,
questions raised.
Hepatology. 2023;77:1463-1464.
- BERARDI G, Ratti F, Sposito C, Nebbia M, et al
Model to predict major complications following liver resection for HCC in
patients with metabolic syndrome.
Hepatology. 2023;77:1527-1539.
- ARTRU F, Rautou PE, Denys A
Letter to the editor: discussing the place of TIPS in noncirrhotic patients with
chronic extrahepatic portal vein occlusion (EHPVO).
Hepatology. 2023;77:E91-E92.
- GU W, Queck A, Trebicka J, Praktiknjo M, et al
Reply: Targeted decrease of portal hepatic pressure gradient immediately after
TIPS improves ascites control and prognosis.
Hepatology. 2023;77:E101.
- KNIGHT GM, Thornburg B, Salem R
Reply: Discussing the place of TIPS in non-cirrhotic patients with chronic extra
hepatic portal vein occlusion refractory to standard of care therapy.
Hepatology. 2023;77:E93-E94.
- RINELLA ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, et al
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic
fatty liver disease.
Hepatology. 2023;77:1797-1835.
- EBRAHIMI F, Ludvigsson JF
Letter to the editor: Association between birth weight, preterm birth, and
nonalcoholic fatty liver disease in a community-based cohort.
Hepatology. 2023;77:E107-E108.
- SANGHA K, Chang ST, Cheung R, Deshpande VS, et al
Cost-effectiveness of MRE versus VCTE in staging fibrosis for nonalcoholic fatty
liver disease (NAFLD) patients with advanced fibrosis.
Hepatology. 2023;77:1702-1711.
Indian J Gastroenterol
- MALAKAR S, Mathur A, Elhence A, Ghoshal UC, et al
Hepatogastric fistula: A rare complication of liver abscess.
Indian J Gastroenterol. 2023 Apr 18. doi: 10.1007/s12664-023-01347.
J Gastroenterol Hepatol
- CHO SH, Song TJ, Park JS, Yoon JH, et al
Comparison of the long-term outcomes between proximal and distal IgG4-related
sclerosing cholangitis: a multicenter cohort study.
J Gastroenterol Hepatol. 2023 Jan 29. doi: 10.1111/jgh.16136.
- ALABBAS SY, Giri R, Oancea I, Davies J, et al
Gut inflammation and adaptive immunity amplify acetaminophen toxicity in bowel
and liver.
J Gastroenterol Hepatol. 2023;38:609-618.
J Hepatol
- ERIKSEN PL, Djernes L, Vilstrup H, Ott P, et al
Clearance and production of ammonia quantified in humans by constant ammonia
infusion - the effects of cirrhosis and ammonia targeting treatments.
J Hepatol. 2023 Apr 13:S0168-8278(23)00220-9. doi: 10.1016/j.jhep.2023.
- DALY AK, Bjornsson ES, Lucena MI, Andrade RJ, et al
Drug-induced liver injury due to nitrofurantoin: Similar clinical features, but
different HLA risk alleles in an independent cohort.
J Hepatol. 2023;78:e165-e166.
- ZHANG H, Peng Y, Tang X
Comment on: Impact of the COVID-19 pandemic on liver disease-related mortality
rates in the United States.
J Hepatol. 2023;78:e177-e178.
- BINET Q, Hermans MP, Lanthier N
Screening for NAFLD and its severity in type 2 diabetic patients: Value of
magnetic resonance imaging and outstanding issues.
J Hepatol. 2023;78:e166-e167.
- RATZIU V, Charlton M
Rational combination therapy for NASH: Insights from clinical trials and error.
J Hepatol. 2023;78:1073-1079.
- SURIAL B, Ramirez Mena A, Roumet M, Limacher A, et al
External validation of the PAGE-B score for HCC risk prediction in people living
with HIV/HBV coinfection.
J Hepatol. 2023;78:947-957.
- ATALLAH E, Grove JI, Crooks C, Burden-Teh E, et al
Risk of liver fibrosis associated with long-term methotrexate therapy may be
overestimated.
J Hepatol. 2023;78:989-997.
- FALKEVALL A, Mehlem A, Folestad E, Ning FC, et al
Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease
development by targeting lipolysis in the white adipose tissue.
J Hepatol. 2023;78:901-913.
- AJMERA V, Loomba R
Reply to: "Screening for NAFLD and its severity in type 2 diabetic patients:
Value of magnetic resonance imaging and outstanding issues".
J Hepatol. 2023;78:e168-e169.
- ZHANG CJ, Meyer SR, O'Meara MJ, Huang S, et al
A human liver organoid screening platform for DILI risk prediction.
J Hepatol. 2023;78:998-1006.
- LEE E, Korf H, Vidal-Puig A
An adipocentric perspective on the development and progression of non-alcoholic
fatty liver disease.
J Hepatol. 2023;78:1048-1062.
- HARRISON SA, Thang C, Bolze S, Dewitt S, et al
Evaluation of PXL065 - deuterium-stabilized (R)-pioglitazone in patients with
NASH: A phase II randomized placebo-controlled trial (DESTINY-1).
J Hepatol. 2023;78:914-925.
- DI MARTINO V
Methotrexate-induced liver fibrosis: The end of a long-held belief.
J Hepatol. 2023;78:896-897.
- FUNDORA Y, Fuster-Anglada C, Bassaganyas C, Toapanta D, et al
An infrequent cause of spontaneous liver rupture.
J Hepatol. 2023;78:e160-e161.
- YIN JL, Ala A, Miquel R
Histology - further raising the diagnostic bar in chronic liver disease.
J Hepatol. 2023;78:e162-e164.
Nat Rev Cancer
- SIMON SM
Author Correction: Fighting rare cancers: lessons from fibrolamellar
hepatocellular carcinoma.
Nat Rev Cancer. 2023 Apr 20. doi: 10.1038/s41568-023-00575.
PLoS One
- CUSHMAN M, Callas PW, Alexander KS, Wadley V, et al
Nonalcoholic fatty liver disease and cognitive impairment: A prospective cohort
study.
PLoS One. 2023;18:e0282633.
- WANG L, Peng Y, Qin S, Wan X, et al
First-line systemic treatment strategies for unresectable hepatocellular
carcinoma: A cost-effectiveness analysis.
PLoS One. 2023;18:e0279786.
- SOHAIL J, Zubair M, Hussain K, Faisal M, et al
Pharmacological activities of Artemisia absinthium and control of hepatic cancer
by expression regulation of TGFbeta1 and MYC genes.
PLoS One. 2023;18:e0284244.
Transplant Proc
- AKBULUT S, Tamer M, Saritas S, Unal O, et al
Immunosuppressive Medication Adherence in Patients With Hepatocellular Cancer Who
Have Undergo Liver Transplantation: A Case Control Study.
Transplant Proc. 2023 Apr 18:S0041-1345(23)00164.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016